Core Viewpoint - The company has shown significant improvement in its financial performance in 2025, with a strong focus on innovation and strategic expansion in the animal health sector, particularly in the pet medicine market [2][3][10]. Financial Performance - In 2024, the company achieved operating revenue of 1.2 billion yuan, a year-on-year increase of 17.71%, but reported a net loss attributable to shareholders of 20.16 million yuan, a decline of 220.11% [2]. - In Q1 2025, the company reported operating revenue of 399 million yuan, a year-on-year increase of 92.96%, and a net profit attributable to shareholders of 44.50 million yuan, a year-on-year increase of 371.23% [3][10]. Business Strategy - The company is focusing on a "raw material - preparation integration" strategy to enhance its competitive edge and profitability, particularly in the raw material drug sector [4][6]. - The company is actively expanding its product offerings in the pet medicine sector, with 8 new veterinary drug certificates obtained and 20 pet medicines launched [8]. Research and Development - The company has made significant advancements in R&D, achieving breakthroughs in microbial fermentation technology and optimizing production processes, which have led to cost reductions [7]. - Plans for 2025 include accelerating the approval and production of new veterinary drugs, with a target of launching at least 20 new products [7]. Market Conditions - The raw material drug market has seen price increases for certain products, driven by rising demand and a shift in focus among manufacturers towards core competitive products [4]. - The company is adapting to changes in the market environment and competition by enhancing its product competitiveness and expanding its market share [10]. Financial Management - The company plans to redeem its convertible bonds early to reduce financial costs, which is expected to save approximately 30 million yuan in expenses [5]. - The company's debt ratio stands at 47.97%, indicating a focus on managing financial risk while pursuing growth [10].

Investment Rating - The report maintains a "Recommended" rating for the agriculture, forestry, animal husbandry, and fishery industry [1] Core Viewpoints - The report highlights strong performance in Q1 and maintains a long-term positive outlook for the pet sector [3] - The pig price is expected to fluctuate weakly, with a long-term bearish outlook for 2025 due to increased supply [5][14] - The poultry sector may see price improvements due to tariff impacts and supply chain adjustments [6][28] - The animal health sector is poised for valuation recovery driven by improved downstream demand and expansion opportunities [7][39] - The planting sector is experiencing a significant decrease in grain imports, which may affect pricing dynamics [8][44] - The feed sector remains at a low level, with expectations of increased industry concentration [9][47] - The pet market continues to grow rapidly, with strong domestic brand performance [10][52] Summary by Sections Pig Industry - Pig prices are expected to adjust slightly downwards, with a long-term bearish trend anticipated for 2025 due to increased production capacity [5][14] - As of April 24, the average pig price was 14.96 CNY/kg, with a slight weekly increase [14] Poultry Industry - The poultry sector may benefit from tariff impacts, with a potential price increase due to supply chain disruptions [6][28] - The industry is expected to stabilize at low production levels, leading to stable profitability [6][29] Animal Health - The animal health sector is seeing improved performance, with significant revenue growth reported by leading companies [7][39] - The prices of key raw materials are rising, which may enhance the performance of related companies [7][39] Planting Sector - A notable decline in grain imports was recorded in March, with a 73.5% year-on-year decrease [8][44] - The prices of major grains have shown some recovery, with corn priced at 2220 CNY/ton as of April 25 [8][44] Feed Industry - Feed prices are currently low, with a slight decrease in the price of pig feed [9][47] - The industry is expected to see increased concentration, with recommendations for leading companies [9][49] Pet Industry - The pet market in China reached a scale of 300.2 billion CNY in 2024, with a year-on-year growth of 7.5% [10][52] - Domestic brands are rapidly gaining market share, with significant growth reported for leading pet food brands [10][56]